ImuVeo

We have developed a T-Cell Tracer, this is the first diagnostic tool for cancer immunotherapy. Our Tracer gives an early and precise answer whether a treatment is working. Meaning results in days or weeks instead of months. No more exposure to ineffective treatment with the risk of possible side effects. Cuts healthcare related costs by up to 80%.